Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6800
+0.0500 (3.07%)
NASDAQ · Last Trade: Mar 28th, 3:30 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors